768 Shares in McKesson Corporation $MCK Purchased by Northbridge Financial Group LLC

Northbridge Financial Group LLC acquired a new position in McKesson Corporation (NYSE:MCK) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 768 shares of the company’s stock, valued at approximately $630,000.

Other institutional investors have also recently bought and sold shares of the company. GGM Financials LLC bought a new position in McKesson in the 3rd quarter worth approximately $25,000. State of Wyoming bought a new position in McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the 3rd quarter worth approximately $31,000. Board of the Pension Protection Fund bought a new position in McKesson in the 4th quarter worth approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC bought a new stake in McKesson during the 3rd quarter worth about $33,000. Institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In related news, Director Maria Martinez sold 349 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the sale, the director owned 301 shares in the company, valued at $282,900.87. This represents a 53.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.08% of the stock is owned by corporate insiders.

McKesson Price Performance

Shares of MCK stock opened at $762.50 on Wednesday. The stock has a market cap of $91.65 billion, a PE ratio of 19.82, a price-to-earnings-growth ratio of 1.16 and a beta of 0.35. The stock has a 50-day moving average of $848.60 and a 200-day moving average of $857.00. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings data on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. During the same quarter in the prior year, the company earned $10.12 EPS. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, research analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio is currently 8.53%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Wells Fargo & Company dropped their target price on shares of McKesson from $925.00 to $812.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. UBS Group upped their target price on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Bank of America dropped their target price on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating for the company in a research report on Monday, April 6th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $875.00 target price on shares of McKesson in a research report on Friday, May 8th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $968.87.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.